Ditosylate salt of itraconazole and dissolution enhancement using cyclodextrins.
Salt formation has been a promising approach for improving the solubility of poorly soluble acidic and basic drugs. The aim of the present study was to prepare the salt form of itraconazole (ITZ), a hydrophobic drug to improve the solubility and hence dissolution performance. Itraconazolium ditolenesulfonate salt (ITZDITOS) was synthesized from ITZ using acid addition reaction with p-toluenesulfonic acid. Salt characterization was performed using (1)H NMR, mass spectrometry, Fourier transform infrared spectroscopy, differential scanning calorimetry, and X-ray diffraction. The particle size and morphology was studied using dynamic light scattering technique and scanning electron microscopy, respectively. The solubility of the salt in water and various pharmaceutical solvents was found multifold than ITZ. The dissolution study exhibited 5.5-fold greater percentage release value in 3 h of ITZDITOS (44.53%) as compared with ITZ (8.54%). Results of in vitro antifungal studies using broth microdilution technique indicate that ITZDITOS possessed similar antifungal profile as that of ITZ when tested against four fungal pathogens. Furthermore, the physical mixtures of ITZDITOS with two cyclodextrins, β-cyclodextrin (β-CD), and 2-hydroxypropyl-β-cyclodextrin (HP-β-CD) were prepared in different molar ratios and were evaluated for in vitro release. It was observed that in only 30 min of dissolution study, about 74 and 81% of drug was released from 1:3 molar ratios of ITZDITOS with β-CD and ITZDITOS with HP-β-CD, respectively, which was distinctly higher than the drug released from ITZ commercial capsules (70%). The findings warrant further preclinical and clinical studies on ITZDITOS so that it can be established as an alternative to ITZ for developing oral formulations.
University Institute of Pharmaceutical Sciences, UGC Centre of Advanced Study, Panjab University, Chandigarh, 160014, India.
Neeraj
N
Kumar
Shishu
Gulshan
G
Bansal
Sandeep
S
Kumar
Asim Kumar
AK
Jana
D002626:Chemistry, Pharmaceutical / Q000379:methods*; D003505:Cyclodextrins / Q000138:chemical synthesis / Q000378:metabolism* / Q000494:pharmacology; D005658:Fungi / Q000187:drug effects / Q000502:physiology; D017964:Itraconazole / Q000138:chemical synthesis / Q000378:metabolism* / Q000494:pharmacology; D008826:Microbial Sensitivity Tests / Q000379:methods; D012492:Salts / Q000138:chemical synthesis / Q000378:metabolism* / Q000494:pharmacology; D012995:Solubility; D014961:X-Ray Diffraction / Q000379:methods
D003505:Cyclodextrins; D012492:Salts; D017964:Itraconazole